Polyomavirus Models of Brain Infection and the Pathogenesis of Multiple Sclerosis

Gerald L Stoner

doi:10.1111/j.1750-3639.1993.tb00748.x

. 2008 Jan 28;3(3):213–227. doi: 10.1111/j.1750-3639.1993.tb00748.x

Polyomavirus Models of Brain Infection and the Pathogenesis of Multiple Sclerosis

Gerald L Stoner ^1,^✉

PMCID: PMC7161790 PMID: 8293181

Abstract

Multiple sclerosis (MS) is generally considered to be an autoimmune disorder with myelin as the target and with several unidentified viruses playing ancillary roles, possibly through molecular mimicry. Although this paradigm has led to important progress on potential mechanisms of myelin loss, neither a target antigen in myelin nor a triggering mechanism has yet been identified, leaving the etiology of MS still unknown. Animal models of viral demyelination and studies showing that JC virus (JCV), the polyomavirus which causes progressive multifocal leukoencephalopathy (PML), may be latent in some normal human brains suggest another possibility. A host immune response targeting proteins expressed at low levels from viral DNA latent in the central nervous system (CNS) might underlie a focal demyelinating disease such as MS. A shift from autoimmunity to a latent‐virus model is not a trivial substitution of target antigens. This shift would expand the search for a definitive laboratory test for MS and could lead to improved therapeutic and preventive approaches.

References

1. Rivers TM, Schwentker FF (1935) Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 61: 689–702. [DOI] [PMC free article] [PubMed] [Google Scholar]
2. Lumsden CE (1970) The neuropathology of multiple sclerosis In: Handbook of Clinical Neurology, Multiple Sclerosis and Other Demyelinating Diseases, Vol. 9, Vinken PJ, Bruyn GW. (eds.), pp. 217–309, North‐Holland: Amsterdam . [Google Scholar]
3. Wisniewski HM, Schuller‐Levis GB, Mehta PD, Madrid RE, Lassmann H. (1985) Pathogenetic aspects of multiple sclerosis and experimental models of inflammatory demyelination. Concepts Immunopathol 2: 128–150. [PubMed] [Google Scholar]
4. Allen IV (1991) Aetiological hypotheses for multiple sclerosis‐evidence from human and experimental diseases In: McAlpine's Multiple Sclerosis, Matthews WB, (ed.), pp. 379–390, Churchill Livingstone: Edinburgh , London , New York . [Google Scholar]
5. Lassmann H., Wisniewski HM (1979) Chronic relapsing experimental allergic encephalomyelitis: Clinicopathological comparison with multiple sclerosis. Arch Neurol 36: 490–497. [DOI] [PubMed] [Google Scholar]
6. Raine CS (1983) Multiple sclerosis and chronic relapsing EAE: Comparative ultrastructural neuropathology In: Multiple Sclerosis ‐ Pathology, Diagnosis and Management, Hallpike JF, Adams CWM, Tourtellotte WW. (eds.), pp. 413–460, Williams & Wilkins: Baltimore . [Google Scholar]
7. Lisak RP (1986) Immunological abnormalities In: Multiple Sclerosis, McDonald WI, Silberberg DH. (eds.), pp. 74–98, Butterworths: London , Boston , Durban . [Google Scholar]
8. Waksman BH (1988) Autoimmunity in demyelinating diseases. Ann N Y Acad Sci 540: 13–24. [DOI] [PubMed] [Google Scholar]
9. Tournier‐Lasserve E., Hashim GA, Bach MA (1988) Human T cell response to myelin basic protein in multiple sclerosis patients and healthy subjects. J Neurosci Res 19: 149–156. [DOI] [PubMed] [Google Scholar]
10. Traugott U. (1990) Evidence for immunopathogenesis In: Handbook of Multiple Sclerosis, Cook SD, (ed.), pp. 101–127, Marcell Dekker: New York . [Google Scholar]
11. Raine CS (1991) Multiple sclerosis: A pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol 17: 265–274. [DOI] [PubMed] [Google Scholar]
12. Lee SJ, Wucherpfennig KW, Brod SA, Benjamin D., Weiner HL, Hafler DA (1991) Common T cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol 29: 33–40. [DOI] [PubMed] [Google Scholar]
13. Martin R., Howell MD, Jaraquemada D., Flerlage M., Richert JR, Brostoff S., Long EO, McFarlin DE, McFarland HF (1991) A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA‐DR types associated with multiple sclerosis. J Exp Med 173: 19–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
14. Chou YK, Henderikx P., Vainiene M., Whitham R., Bourdette D., Chou CH, Hashim G., Offner H., Vandenbark AA (1991) Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein. J Neurosci Res 28: 280–290. [DOI] [PubMed] [Google Scholar]
15. Oksenberg JR, Stuart S., Begovich AB, Bell RB, Erlich HA, Steinman L., Bernard CC (1990) Limited heterogeneity of rearranged T cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature 345: 344–346. [DOI] [PubMed] [Google Scholar]
16. Ota K., Matsui M., Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183–187. [DOI] [PubMed] [Google Scholar]
17. Vandenbark AA, Chou YK, Bourdette D., Whitham R., Chilgren J., Chou CH, Konat G., Hashim G., Vainiene M., Offner H. (1989) Human T lymphocyte response to myelin basic protein: Selection of T lymphocyte lines from MBP‐responsive donors. J Neurosci Res 23: 21–30. [DOI] [PubMed] [Google Scholar]
18. Liblau R., Tournier‐Lasserve E., Maciazek J., Dumas G., Siffert O., Hashim G., Bach MA (1991) T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects. Eur J Immunol 21: 1391–1395. [DOI] [PubMed] [Google Scholar]
19. Richert JR, Robinson ED, Martin R., McFarland HF, Hurley CK (1991) T cell receptor gene rearrangements in the human response to myelin basic protein. Ann N Y Acad Sci 636: 396–399. [DOI] [PubMed] [Google Scholar]
20. Martin R., Utz U., Coligan JE, Richert JR, Flerlage M., Robinson ED, Stone R., Biddison WE, McFarlin DE, McFarland HF (1992) Diversity in fine specificity and T cell receptor usage of the human CD4⁺ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87–106. J Immunol 148: 1359–1366. [PubMed] [Google Scholar]
21. Jingwu Z., Medaer R., Hashim GA, Chin Y., Van den Berg‐Loonen E. Raus JCM (1992) Myelin basic protein‐specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 32: 330–338. [DOI] [PubMed] [Google Scholar]
22. Leibowitz S. (1992) The immunology of multiple scleorsis In: Multiple Sclerosis‐Pathology, Diagnosis and Management, Hallpike JF, Adams CWM, Tourtellotte WW. (eds.), pp. 379–412, Williams & Wilkins: Baltimore . [Google Scholar]
23. McFarland HF (1988) Immunology of multiple sclerosis. Ann N Y Acad Sci 540: 99–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
24. Bradbury K. (1987) Serum demyelinating activity in multiple sclerosis In: Multiple Sclerosis: Immunological, Diagnostic, and Therapeutic Aspects, Rose FC, Jones R. (eds.), pp. 43–49, John Libby: London , Paris . [Google Scholar]
25. Martin R., McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10: 153–187. [DOI] [PubMed] [Google Scholar]
26. Neumeyer DA, Hirsch MS (1986) Inversion of T cell subsets before herpes zoster infection. New Engl J Med 314: 1456. [DOI] [PubMed] [Google Scholar]
27. Saeki Y., Mima T., Sakoda S., Fujimura H., Arita N., Nomura T., Kishimoto T. (1992) Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc Natl Acad Sci USA 89: 6157–6161. [DOI] [PMC free article] [PubMed] [Google Scholar]
28. Lipton HL (1975) Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect Immun 11: 1147–1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
29. Johnson RT (1985) Viral aspects of multiple sclerosis In: Handbook of Clinical Neurology, Demyelinating Diseases, Vol. 47, Koetsier JC, (ed.), pp. 319–336, Elsevier Science: Amsterdam , New York . [Google Scholar]
30. Barnett LA, Fujinami RS (1992) Molecular mimicry: A mechanism for autoimmune injury. FASEB J 6: 840–844. [DOI] [PubMed] [Google Scholar]
31. Booss J., Kim JH (1990) Evidence for a viral etiology of multiple sclerosis In: Handbook of Multiple Sclerosis, Cook SD, (ed.), pp. 41–61, Marcell Dekker: New York . [Google Scholar]
32. Dal Canto MC, Rabinowitz SG (1982) Experimental models of virus‐induced demyelination of the central nervous system. Ann Neurol 11: 109–127. [DOI] [PMC free article] [PubMed] [Google Scholar]
33. Mims CA, Kelly RE, Cuzner ML (1983) Viruses and Demyelinating Diseases, Academic Press: London , New York . [Google Scholar]
34. Rodriguez M., Oleszak E., Leibowitz J. (1987) Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus. CRC Crit Rev Immunol 7: 325–365. [PubMed] [Google Scholar]
35. Watanabe R., Wege H., ter Meulen V. (1983) Adoptive transfer of EAE‐like lesions from rats with coronavirus‐induced demyelinating encephalomyelitis. Nature 305: 150–153. [DOI] [PMC free article] [PubMed] [Google Scholar]
36. Buchmeier MJ, Dalziel RG, Koolen MJM (1988) Corona‐virus‐induced CNS disease: A model for virus‐induced demyelination. J Neuroimmunol 20: 111–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
37. Wege H., Winter J., Körner H., Flory E., Zimprich F., Lassmann H. (1990) Coronavirus induced demyelinating encephalomyelitis in rats: Immunopathological aspects of viral persistency. Adv Exp Med Biol 276: 637–645. [DOI] [PubMed] [Google Scholar]
38. Johnson RT, Griffen DE, Hisrch RL, Wolinsky JS, Roedenbeck S., Lindo de Soriano I., Vaisberg A. (1984) Measles encephalomyelitis‐Clinical and immunological studies. N Engl J Med 310: 137–141. [DOI] [PubMed] [Google Scholar]
39. Rodriguez M. (1992) Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. J Neuroimmunol 40: 255–264. [DOI] [PubMed] [Google Scholar]
40. McFarlin DE, Blattner WA (1991) Non‐AIDS retroviral infections in humans. Annu Rev Med 42: 97–105. [DOI] [PubMed] [Google Scholar]
41. Bray PF, Culp KW, McFarlin DE, Panitch HS, Torkelson RD, Schlight JP (1992) Demyelinating disease after neurologically complicated Epstein‐Barr virus infection. Neurology 42: 278–282. [DOI] [PubMed] [Google Scholar]
42. Murray RS, Brown B., Brian D., Cabirac GF (1992) Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 31: 525–533. [DOI] [PMC free article] [PubMed] [Google Scholar]
43. Stewart JN, Mounir S., Talbot PJ (1992) Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 191: 502–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
44. Kastrukoff LF, Lau AS, Leung GY, Walker D., Thomas EE (1992) Herpes simplex virus type 1‐induced multifocal central nervous system (CNS) demyelination in mice. J Neuropathol Exp Neurol 51: 432–439. [DOI] [PubMed] [Google Scholar]
45. Cosby SL, Mcquaid S., Taylor MJ, Bailey M., Rima BK, Martin SJ, Allen IV (1989) Examination of eight cases of multiple sclerosis and 56 neurological and non‐neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol 70: 2027–2036. [DOI] [PubMed] [Google Scholar]
46. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova‐like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257–1260. [DOI] [PubMed] [Google Scholar]
47. Gardner SD, Field AM, Coleman DV, Hulme B. (1971) New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet i: 1253–1257. [DOI] [PubMed] [Google Scholar]
48. Walker DL, Padgett BL (1983) The epidemiology of human polyomaviruses In: Polyomaviruses and Human Neurological Disease, Sever JL, Madden DL. (eds.), pp. 99–106, Alan R Liss: New York . [Google Scholar]
49. Åström KE, Mancall EL, Richardson EP Jr, (1958) Progressive multifocal leuko‐encephalopathy: A hitherto unrecognized complication of chronic lymphocytic leukemia and Hodgkin's disease. Brain 81: 93–111. [DOI] [PubMed] [Google Scholar]
50. Walker DL (1985) Progressive multifocal leukoencephalopathy In: Handbook of Clinical Neurology, Demyelinating Diseases, Vol. 47, Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC. (eds.), pp. 503–524, Elsevier Science: Amsterdam , New York . [Google Scholar]
51. Greenlee JE (1989) Papovavirus infections of the nervous system In: Clinical and Molecular Aspects of Neurotropic Virus Infection, Gilden DH, Lipton HL. (eds.), pp. 319–342, Kluwer Academic Publishers: Boston . [Google Scholar]
52. Frisque RJ, White FA III (1992) The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy In: Neurovirology ‐ Pathogenesis of Viral CNS Infections, Roos RP, (ed.), pp. 25–158, Humana Press: Totowa . [Google Scholar]
53. Major EO, Amemiya K., Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus‐induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
54. White FA III, Ishaq M., Stoner GL, Frisque RJ (1992) JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 66: 5726–5734. [DOI] [PMC free article] [PubMed] [Google Scholar]
55. Mori M., Aoki N., Shimada H., Tajima M., Kato K. (1992) Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci Lett 141: 151–155. [DOI] [PubMed] [Google Scholar]
56. Quinlivan EB, Norris M., Bouldin TW, Suzuki K., Meeker R., Smith MS, Hall C., Kenney S. (1992) Subclinical central nervous system infection with JC virus in patients with AIDS. J Infect Dis 166: 80–85. [DOI] [PubMed] [Google Scholar]
57. Elsner C., Dörries K. (1992) Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 191: 72–80. [DOI] [PubMed] [Google Scholar]
58. Mori M., Kurata H., Tajima M., Shimada H. (1991) JC virus detection by in situ hybridization in brain tissue from elderly patients. Ann Neurol 29: 428–432. [DOI] [PubMed] [Google Scholar]
59. Itoyama Y., Webster HdeF, Sternberger NH, Richardson EP Jr, Walker DL, Quarles RH, Padgett BL (1982) Distribution of papovavirus, myelin‐associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann Neurol 11: 396–407. [DOI] [PubMed] [Google Scholar]
60. Johnson RT, Narayan O., Weiner LP, Greenlee JE (1977) Progressive multifocal leukoencephalopathy In: Slow Virus Infections of the Central Nervous System, TerMeulen V., Katz M. (eds.), pp. 91–105, Springer‐Verlag: New York . [Google Scholar]
61. McDonald WI, Silberberg DH (1986) Multiple Sclerosis, Butterworths: London , Boston , Durban . [Google Scholar]
62. Rose FC, Jones R. (1987) Multiple Sclerosis: Immunological, Diagnostic, and Therapeutic Aspects, John Libby: London , Paris . [Google Scholar]
63. Cook SD (1990) Handbook of Multiple Sclerosis, Marcell Dekker: New York . [Google Scholar]
64. Matthews WB, Compston A., Allen IV, Martyn CN (1991) McAlpine's Multiple Sclerosis, 2nd Ed, Churchill Livingstone: Edinburgh , London , New York . [Google Scholar]
65. Howley PM (1980) Molecular biology of SV40 and the human polyomaviruses BK and JC In: Viral Oncology, Klein G., (ed.), pp. 489–550, Raven Press: New York . [Google Scholar]
66. Padgett BL (1980) Human papovaviruses In: Molecular Biology of Tumor Viruses: DNA Tumor Viruses, Tooze J., (ed.), pp. 339–370, Cold Spring Harbor Laboratory: Cold Spring Harbor . [Google Scholar]
67. ZuRhein GM (1983) Studies of JC virus‐induced nervous system tumors in the Syrian hamster In: Polyomaviruses in Human Neurological Diseases, Sever JL, Madden DL. (eds.), pp. 205–221, Alan R Liss: New York . [Google Scholar]
68. Monier R. (1986) Transformation by SV40 and polyoma In: The Papovaviridae Volume 1 The Polyomaviruses, Salzman NP, (ed.), pp. 247–294, Plenum Press: New York , London . [Google Scholar]
69. Villarreal LP (1989) Common Mechanisms of Transformation by Small DNA Tumor Viruses, American Society for Microbiology: Washington , D.C . [Google Scholar]
70. London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M., Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM, Ohashi T. (1978) Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201: 1246–1249. [DOI] [PubMed] [Google Scholar]
71. Pagnani M., Negrini M., Reschiglian R. Corallini A., Balboni PG, Schemeck S., Macino G., Milanesi G., Barbanti‐Brodano G. (1986) Molecular and biological properties of BK virus‐IR, a BK virus variant isolated from a human tumor. J Virol 59: 500–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
72. Dörries K., Loeber G., Meixensberger J. (1987) Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology 160: 268–270. [DOI] [PubMed] [Google Scholar]
73. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326: 988–993. [DOI] [PubMed] [Google Scholar]
74. Gribble DH, Haden CC, Schwartz LW, Henrickson RV (1975) Spontaneous progressive multifocal leukoencephalopathy (PML) in macaques. Nature 254: 602–604. [DOI] [PubMed] [Google Scholar]
75. Holmberg CA, Hendrickson R., Anderson J., Osburn BI (1985) Malignant lymphoma in a colony of Macaca arctoides. Vet Path 22: 42–45. [DOI] [PubMed] [Google Scholar]
76. Horvath CJ, Simon MA, Bergsagel DJ, Pauley DR, King NW, Garcea RL, Ringler DJ (1992) Simian virus 40‐induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. Am J Pathol 140: 1431–1440. [PMC free article] [PubMed] [Google Scholar]
77. Holmberg CA, Gribble DH, Takemoto KK, Howley PM, Espana C., Osburn BI (1977) Isolation of simian virus 40 from rhesus monkeys (Macaca mulatta) with spontaneous progressive multifocal leukoencephalopathy. J Infect Dis 136: 593–596. [DOI] [PubMed] [Google Scholar]
78. Ilyinskii PO, Daniel MD, Horvath CJ, Desrosiers RC (1992) Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J Virol 66: 6353–6360. [DOI] [PMC free article] [PubMed] [Google Scholar]
79. Walker DL, Frisque RJ (1986) The biology and molecular biology of JC virus In: The Papovaviridae Volume 1 The Polyomaviruses, Salzman NP, (ed.), pp. 327–377, Plenum Press: New York . [Google Scholar]
80. Stoner GL, Soffer D., Ryschkewitsch CF, Walker DL, Webster Hde F. (1988) A double‐label method detects both early (T‐antigen) and late (capsid) proteins of JC virus in progressive multifocal leukoencephalopathy brain tissue from AIDS and non‐AIDS patients. J Neuroimmunol 19: 223–236. [DOI] [PubMed] [Google Scholar]
81. Richardson EP Jr (1961) Progressive multifocal leukoencephalopathy. New Engl J Med 265: 815–823. [DOI] [PubMed] [Google Scholar]
82. Loeber G., Dörries K. (1988) DNA rearrangements in organ‐specific variants of polyomavirus JC strain GS. J Virol 62: 1730–1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
83. Yogo Y., Kitamura T., Sugimoto C., Ueki T., Aso Y., Hara K., Taguchi F. (1990) Isolation of a possible archetypal JC virus DNA sequence from non‐immunocompromised individuals. J Virol 64: 3139–3143. [DOI] [PMC free article] [PubMed] [Google Scholar]
84. Buckle GJ, Godec MS, Rubi JU, Tornatore C., Major EO, Gajdusek DC, Asher DM (1992) Lack of JC viral genomic sequence in multiple sclerosis brain tissue by polymerase chain reaction. Ann Neurol 32: 829–831. [DOI] [PubMed] [Google Scholar]
85. Heinonen O., Syrjänen S., Mäntyjärvi R., Syrjänen K., Riekkinen P. (1992) JC virus infection and Alzheimer's disease: Reappraisal of an in situ hybridization approach. Ann Neurol 31: 439–441. [DOI] [PubMed] [Google Scholar]
86. Lipton HL (1991) Is JC virus latent in brain Ann Neurol 29: 433–434. [DOI] [PubMed] [Google Scholar]
87. Budka H., Costanzi G., Cristina S., Lechi A., Parravicini C., Trabattoni R., Vago L. (1987) Brain pathology induced by infection with human immunodeficiency virus (HIV). A histological immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Berl) 75: 185–198. [DOI] [PubMed] [Google Scholar]
88. Lang W., Miklossy J., Deruaz JP, Pizzolato GP, Probst A., Schaffner T., Gessaga E., Kleihues P. (1989) Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (Berl) 77: 379–390. [DOI] [PubMed] [Google Scholar]
89. Chowdhury M., Taylor JP, Tada H., Rappaport J., Wong Staal F., Amini S., Khalili K. (1990) Regulation of the human neurotropic virus promoter by JCV‐T antigen and HIV‐1 tat protein. Oncogene 5: 1737–1742. [PubMed] [Google Scholar]
90. Tada H., Rappaport J., Lashgari M., Amini S., Wong‐Staal F., Khalili K. (1990) Trans‐activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87: 3479–3483. [DOI] [PMC free article] [PubMed] [Google Scholar]
91. Chowdhury M., Taylor JP, Chang C‐F, Rappaport J., Khalili K. (1992) Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 66: 7355–7361. [DOI] [PMC free article] [PubMed] [Google Scholar]
92. Orenstein JM, Jannotta F. (1990) Human immunodeficiency virus and papovavirus infections in acquired immunodeficiency syndrome: An ultrastructural study of three cases. Hum Pathol 19: 350–361. [DOI] [PubMed] [Google Scholar]
93. Wiley CA, Grafe M., Kennedy C., Nelson JA (1988) Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl) 76: 338–346. [DOI] [PubMed] [Google Scholar]
94. Vazeux R., Cumont M., Girard PM, Nassif X., Trotot P., Marche C., Matthiessen L., Vedrenne C., Mikol J., Henin D. (1990) Severe encephalitis resulting from coinfections with HIV and JC virus. Neurology 40: 944–948. [DOI] [PubMed] [Google Scholar]
95. Helland DE, Welles JL, Caputo A., Haseltine WA (1991) Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol 65: 4547–4549. [DOI] [PMC free article] [PubMed] [Google Scholar]
96. Marcuzzi A., Weinberger J., Weinberger OK (1992) Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol 66: 4228–4232. [DOI] [PMC free article] [PubMed] [Google Scholar]
97. Rodriguez M., Pease LR, David CS (1986) Immune‐mediated injury of virus‐infected oligodendrocytes: A model of multiple sclerosis. Immunol Today 7: 359–363. [DOI] [PubMed] [Google Scholar]
98. Stoner GL (1991) Implications of progressive multifocal leukoencephalopathy and JC virus for the etiology of MS. Acta Neurol Scand 83: 20–33. [PubMed] [Google Scholar]
99. Phadke JG, Best PV (1983) Atypical and clinically silent multiple sclerosis: A report of 12 cases discovered unexpectedly at autopsy. J Neurol Neurosurg Psychiatry 46: 414–420. [DOI] [PMC free article] [PubMed] [Google Scholar]
100. Gilbert JJ, Sadler RM (1983) Unsuspected multiple sclerosis. Arch Neurol 40: 533–536. [DOI] [PubMed] [Google Scholar]
101. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S., Hader W., Murray TJ, Seland TP, Duquette P., Grey T., Nelson R., Nicolle M., Brunet D. (1986) A population‐based study of multiple sclerosis in twins. N Engl J Med 315: 1638–1642. [DOI] [PubMed] [Google Scholar]
102. Tienari PJ, Salonen O., Wikström J., Valanne L., Palo J. (1992) Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 55: 883–886. [DOI] [PMC free article] [PubMed] [Google Scholar]
103. Paty DW (1990) Neuroimaging in multiple sclerosis In: Handbook of Multiple Sclerosis, Cook SD, (ed), pp. 291–316, Marcell Dekker: New York . [Google Scholar]
104. Coleman DV, Gardner SD, Mulholland C., Fridiksdottir V., Porter AA, Lilford R., Valdimarsson H. (1983) Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation. Clin Exp Immunol 53: 289–296. [PMC free article] [PubMed] [Google Scholar]
105. Arthur RR, Shah KV (1989) Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol 36: 42–61. [PubMed] [Google Scholar]
106. Markowitz R‐B, Thompson HC, Mueller JF, Cohen JA, Dynan WS (1993) Incidence of BK virus and JC virus viruria in human immunodeficiency virus‐infected and uninfected subjects. J Infect Dis 167: 13–20. [DOI] [PubMed] [Google Scholar]
107. Brinton MA, Blank KJ, Nathanson N. (1984) Host genes that influence susceptibility to viral diseases In: Concepts in Viral Pathogenesis, Notkins AL, Oldstone MBA. (eds.), pp. 71–78, Springer‐Verlag: New York . [Google Scholar]
108. Skamene E., Pietrangeli CE (1991) Genetics of the immune response to infectious pathogens. Curr Opin Immunol 3: 511–517. [DOI] [PubMed] [Google Scholar]
109. Oksenberg JR, Steinman L. (1989) The role of the MHC and T cell receptor in susceptibility to multiple sclerosis. Curr Opin Immunol 2: 619–621. [DOI] [PubMed] [Google Scholar]
110. Yogo Y., Iida T., Taguchi F., Kitamura T., Aso Y. (1991) Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J Clin Microbiol 29: 2130–2138. [DOI] [PMC free article] [PubMed] [Google Scholar]
111. Ault GS, Stoner GL (1992) Two major types of JC virus defined in PML brain by early and late region DNA coding sequence. J Gen Virol 73: 2669–2678. [DOI] [PubMed] [Google Scholar]
112. Fanning E., Knippers R. (1992) Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem 61: 55–85. [DOI] [PubMed] [Google Scholar]
113. Kuroiwa Y., Kurland LT (1982) Multiple Sclerosis East and West, Karger: Basel . [Google Scholar]
114. Begovich AB, Helmuth RC, Oksenberg JR, Sakai K., Tabira T., Sasazuki T., Steinman L., Erlich HA (1990) HLA‐DP beta and susceptibility to multiple sclerosis: An analysis of caucasoid and Japanese patient populations. Hum Immunol 28: 365–372. [DOI] [PubMed] [Google Scholar]
115. Chittenden T., Frey A., Levine AJ (1991) Regulated replication of an episomal simian virus 40 origin plasmid in COS7 cells. J Virol 65: 5944–5951. [DOI] [PMC free article] [PubMed] [Google Scholar]
116. Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51: 458–469. [DOI] [PMC free article] [PubMed] [Google Scholar]
117. Dörries K., ter Meulen V. (1983) Progressive multifocal leucoencephalopathy: Detection of papovavirus JC in kidney tissue. J Med Virol 11: 307–317. [DOI] [PubMed] [Google Scholar]
118. Grinnell BW, Padgett BL, Walker DL (1983) Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy. J Infect Dis 147: 669–675. [DOI] [PubMed] [Google Scholar]
119. Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S., Roberts JR, Gitt J., Saini N., Lux W. (1988) Involvement of JC virus‐infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318: 301–305. [DOI] [PubMed] [Google Scholar]
120. Stoner GL, Mazlo M., Ryschkewitsch CF, Walker DL, Webster Hde F. (1988) Cerebellar progressive multifocal leukoencephalopathy: Localization of JC virus T‐antigen in granule cell neurons. Ann Neurol 24: 475 (abstr). [Google Scholar]
121. Stoner GL, Ryschkewitsch CF, Walker DL, Webster Hde F. (1986) JC papovavirus large tumor (T)‐antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non‐AIDS patients with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 83: 2271–2275. [DOI] [PMC free article] [PubMed] [Google Scholar]
122. Dörries K., Johnson RT, ter Meulen V. (1979) Detection of polyoma virus DNA in PML‐brain tissue by (in situ) hybridization. J Gen Virol 42: 49–57. [DOI] [PubMed] [Google Scholar]
123. Fareed GC, Takemoto KK, Gimbrone MA Jr (1978) Interaction of simian virus 40 and human papovaviruses, BK and JC, with human vascular endothelial cells In: Microbiology ‐ 1978, Schlessinger D., (ed.), pp. 427–431, American Society for Microbiology: Washington , D.C . [Google Scholar]
124. Ressetar HG, Webster Hde F., Stoner GL (1992) Brain vascular endothelial cells express JC virus large tumor antigen in immunocompetent and cyclophosphamide‐treated hamsters. Proc Natl Acad Sci USA 89: 8170–8174. [DOI] [PMC free article] [PubMed] [Google Scholar]
125. Pardridge WM (1992) Advances in cell biology of blood‐brain barrier transport. Sem Cell Biol 2: 419–426. [PubMed] [Google Scholar]
126. Babé LM, Brew K., Matsuura SE, Scott WA (1989) Epitopes on the major capsid protein of simian virus 40. J Biol Chem 264: 2665–2671. [PubMed] [Google Scholar]
127. Ressetar HG, Walker DL, Webster Hde F., Braun DG, Stoner GL (1990) Immunolabeling of JC virus large T antigen in neonatal hamster brain before tumor formation. Lab Invest 62: 287–296. [PubMed] [Google Scholar]
128. Adams JH, Short IA (1965) Progressive multifocal leucoencephalopathy. A neurological complication of diseases involving the reticulo‐endothelial system. Scot Med J 10: 195–202. [PubMed] [Google Scholar]
129. D'Agostino AN, Pease GL, Kernohan JW (1963) Cerebral demyelination associated with polycythemia vera. J Neuropathol Exp Neurol 22: 138–147. [DOI] [PubMed] [Google Scholar]
130. Zu Rhein GM (1969) Association of papova‐virions with a human demyelinating disease (progressive multifocal leukoencephalopathy). Prog Med Virol 11: 185–247. [PubMed] [Google Scholar]
131. Chandor SB, Forno LS, Wivel NA (1965) Progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 28: 260–271. [DOI] [PMC free article] [PubMed] [Google Scholar]
132. Åström KE, Stoner GL (1990) Asymptomatic progressive multifocal leukoencephalopathy (PML) with early lesions discovered at autopsy. J Neuropathol Exp Neurol 49: 302 (abstr). [Google Scholar]
133. Sloof JL (1966) Two cases of progressive multifocal leukoencephalopathy with unusual aspects. Psychiat Neurol Neurochir 69: 461–474. [PubMed] [Google Scholar]
134. Watanabe I., Preskorn SH (1976) Virus‐cell interaction in oligodendroglia, astroglia and phagocyte in progressive multifocal leukoencephalopathy. An electron microscopic study. Acta Neuropathol (Berl) 36: 101–115. [DOI] [PubMed] [Google Scholar]
135. Mázlô M., Tariska I (1982) Are astrocytes infected in progressive multifocal leukoencephalopathy (PML) Acta Neuropathol (Berl) 56: 45–51. [DOI] [PubMed] [Google Scholar]
136. Johnson RT, Mims CA (1968) Pathogenesis of viral infections of the nervous system. New Engl J Med 278: 84–92. [DOI] [PubMed] [Google Scholar]
137. Knowles WA, Gibson PE, Gardner SD (1989) Serological typing scheme for BK‐like isolates of human polyomavirus. J Med Virol 28: 118–123. [DOI] [PubMed] [Google Scholar]
138. Tavis JE, Frisque RJ, Walker DL, White FA III (1990) Antigenic and transforming properties of the DB strain of the human polyomavirus BK virus. Virology 178: 568–572. [DOI] [PubMed] [Google Scholar]
139. Tavis JE, Walker DL, Gardner SD, Frisque RJ (1989) Nucleotide sequence of the human polyomavirus AS virus, an antigenic variant of BK virus. J Virol 63: 901–911. [DOI] [PMC free article] [PubMed] [Google Scholar]
140. Negrini M., Sabbioni S., Arthur RR, Castagnoli A., Barbanti Brodano G. (1991) Prevalence of the archetypal regulatory region and sequence polymorphisms in non‐passaged BK virus variants. J Virol 65: 5092–5095. [DOI] [PMC free article] [PubMed] [Google Scholar]
141. Willoughby E., Price RW, Padgett BL, Walker DL, Dupont B. (1980) Progressive multifocal leukoencephalopathy (PML): In vitro cell‐mediated immune responses to mitogens and JC virus. Neurology 30: 256–262. [DOI] [PubMed] [Google Scholar]
142. Drummond JE, Shah KV, Donnenberg AD (1985) Cell‐mediated immune responses to BK virus in normal individuals. J Med Virol 17: 237–247. [DOI] [PubMed] [Google Scholar]
143. Dupuis M., Fernandes Xavier FG, Gonsette RE, Brucher JM (1986) Progressive multifocal leukoencephalopathy mimicking multiple sclerosis as only manifestation of an acquired immune deficiency syndrome. Acta Neurol Belg 86: 285–296. [PubMed] [Google Scholar]
144. Berger JR, Sheremata WA, Resnick L., Atherton S., Fletcher MA, Norenberg M. (1989) Multiple sclerosis like illness occurring with human immunodeficiency virus infection. Neurology 39: 324–329. [DOI] [PubMed] [Google Scholar]
145. Brew BJ (1991) MS‐like leukoencephalopathy in HIV‐1. Neurology 41: 1166. [DOI] [PubMed] [Google Scholar]
146. Gray F., Chimelli L., Mohr M., Clavelou P., Scaravilli F., Poirier J. (1991) Fulminating multiple sclerosis‐like leukoencephalopathy revealing human immunodeficiency virus infection. Neurology 41: 105–109. [DOI] [PubMed] [Google Scholar]
147. Berger JR, Tornatore C., Major EO, Bruce J., Shapshak P., Yoshioka M., Houff S., Sheremata W., Horton GF, Landy H. (1992) Relapsing and remitting human immunodeficiency virus‐associated leukoencephalomyelopathy. Ann Neurol 31: 34–38. [DOI] [PubMed] [Google Scholar]
148. Upton H., Miller S., Melvold R., Fujinami RS (1986) Theiler's murine encephalomyelitis virus (TMEV) infection in mice as a model for multiple sclerosis In: Concepts in Viral Pathogenesis II, Notkins AL, Oldstone MBA. (eds.), pp. 248–254, Springer‐Verlag: New York . [Google Scholar]
149. Small JA, Scangos GA, Cork L., Jay G., Khoury G. (1986) The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell 46: 13–18. [DOI] [PubMed] [Google Scholar]
150. Trapp BD, Small JA, Pulley M., Khoury G., Scangos GA (1988) Dysmyelination in transgenic mice containing JC virus early region. Ann Neurol 23: 38–48. [DOI] [PubMed] [Google Scholar]
151. Baron‐Van Evercooren A., Jensen NA, Wyss MT, Cuzin F., Rassoulzadegan M., Brucher JM, Baron H. (1992) Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system. Lab Invest 66: 39–53. [PubMed] [Google Scholar]
152. Hogan TF, Padgett BL, Walker DL (1991) Human Polyomaviruses In: Textbook of Human Virology, Belshe RB, (ed.), pp. 970–1000, Mosby: St. Louis . [Google Scholar]
153. Meurman OH, Mäntyjärvi RA, Salmi AA, Panelius M. (1972) Prevalence of antibodies to a human papova virus (BK virus) in subacute sclerosing panencephalitis and multiple sclerosis patients. Z Neurol 203: 191–194. [DOI] [PubMed] [Google Scholar]
154. Roizin L., Haymaker W., D'Amelio F. (1982) Disease states involving the white matter of the central nervous system. Part I. The primary demyelinating diseases In: Histology and Histopathology of the Nervous System, Haymaker W., Adams RD. (eds.), pp. 1276–1361, Charles C Thomas: Springfield . [Google Scholar]
155. Fog T. (1965) The topography of plaques in multiple sclerosis. Acta Neurol Scand (Suppl) 15: 1–161. [PubMed] [Google Scholar]
156. Harris JO, Frank JA, Patronas N., McFarlin DE, McFarland HF (1991) Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history. Ann Neurol 29: 548–555. [DOI] [PubMed] [Google Scholar]
157. Thompson AJ, Kermode AG, Wicks D., MacManus DG, Kendall BE, Kingsley DP, McDonald WI (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29: 53–62. [DOI] [PubMed] [Google Scholar]
158. McDonald WI, Barnes D. (1989) Lessons from magnetic resonance imaging in multiple sclerosis. Trends Neurosci 12: 376–379. [DOI] [PubMed] [Google Scholar]
159. ZuRhein GM, Varakis JN (1979) Perinatal induction of medulloblastomas in Syrian golden hamsters by a human polyoma virus (JC) In: Perinatal Carcinogenesis, National Cancer Institute Monograph 51, Rice JM, (ed.), pp. 205–208, U.S. Dept. of Health, Education and Welfare: Washington , D.C . [PubMed] [Google Scholar]
160. Takakura K., Inoya H., Nagashima K. (1987) Viral neurooncogenesis. Prog Exp Tumor Res 30: 10–20. [PubMed] [Google Scholar]
161. Reagan TJ, Freiman IS (1973) Multiple cerebral gliomas in multiple sclerosis. J Neurol Neurosurg Psychiatry 36: 523–528. [DOI] [PMC free article] [PubMed] [Google Scholar]
162. Russell DS, Rubinstein LJ (1977) Pathology of Tumors of the Nervous System, 4th Ed, p. 271, Williams & Wilkins: Baltimore . [Google Scholar]
163. Anderson M., Hughes B., Jefferson M., Smith WT, Waterhouse JAH (1980) Gliomatous transformation and demyelinating diseases. Brain 103: 603–622. [DOI] [PubMed] [Google Scholar]
164. Malmgren RM, Detels R., Verity MA (1984) Co‐occurrence of multiple sclerosis and glioma ‐ Case report and neuropathology and epidemiologic review. Clin Neuropath 3: 1–9. [PubMed] [Google Scholar]
165. Turpin JC, Peruzzi P., Pluot M. (1988) Sclérose en plaques et gliome cérébral. Sem Hôp Paris 64: 1151–1158. [Google Scholar]
166. Aarli JA, Mörk SJ, Myrseth E., Larsen JL (1989) Glioblastoma associated with multiple sclerosis: Coincidence or induction Eur Neurol 29: 312–316. [DOI] [PubMed] [Google Scholar]
167. Castaigne P., Rondot P., Escourolle R., Ribadeau dumas JL, Cathala F., Hauw JJ (1974) Leucoencephalopathie multifocale progressive et ‘gliomes’ multiples. Rev Neurol (Paris) 130: 379–392. [PubMed] [Google Scholar]
168. Sima AA, Finkelstein SD, McLachlan DR (1983) Multiple malignant astrocytomas in a patient with spontaneous progressive multifocal leukoencephalopathy. Ann Neurol 14: 183–188. [DOI] [PubMed] [Google Scholar]
169. Shepherd DI, Downie AW, Best PV (1974) Systemic lupus erythematosis and multiple sclerosis. Trans Am Neurol Assoc 99: 173–176. [PubMed] [Google Scholar]
170. Newton P., Aldridge RD, Lessells AM, Best PV (1986) Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus. Arthritis Rheum 29: 337–343. [DOI] [PubMed] [Google Scholar]
171. Stoner GL, Best PV, Mazlo M., Ryschkewitsch CF, Walker DL, Webster Hde F. (1988) Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus: Distribution of JC virus in chronically demyelinated cerebellar lesions. J Neuropathol Exp Neurol 47: 307 (abstr). [Google Scholar]
172. Poser CM (1992) Multiple sclerosis. Observations and reflections‐A personal memoir. J Neurol Sci 107: 127–140. [DOI] [PubMed] [Google Scholar]
173. Selmaj K., Raine CS, Cannella B., Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949–954. [DOI] [PMC free article] [PubMed] [Google Scholar]
174. Hughes RAC (1992) Pathogenesis of multiple sclerosis. J R Soc Med 85: 373–376. [PMC free article] [PubMed] [Google Scholar]
175. Selmaj K., Raine CS, Cross AH (1991) Anti‐tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30: 694–700. [DOI] [PubMed] [Google Scholar]
176. Steinman L. (1991) The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv Immunol 49: 357–379. [DOI] [PubMed] [Google Scholar]
177. Hafler DA, Cohen I., Benjamin DS, Weiner HL (1992) T cell vaccination in multiple sclerosis: A preliminary report. Clin Immunol Immunopathol 62: 307–313. [DOI] [PubMed] [Google Scholar]
178. Arnason BGW (1992) Multiple sclerosis: Additional thoughts. J Neurol Sci 107: 141–144. [DOI] [PubMed] [Google Scholar]
179. Hillert J., Olerup O. (1992) Debate: Do TCR genes influence susceptibility to autoimmune disease in humans? Germline polymorphism of TCR genes and disease susceptibility ‐ Fact or hypothesis. Immunol Today 13: 47–49. [DOI] [PubMed] [Google Scholar]
180. Webb HE (1992) Multiple sclerosis: Therapeutic pessimism. Brit Med J 304: 1260–1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
181. Weinshenker BG, Sibley WA (1992) Natural history and treatment of multiple sclerosis. Curr Opin Neurol Neurosurg 5: 203–211. [PubMed] [Google Scholar]
182. Bernard CCA, de Rosbo NK (1992) Multiple sclerosis: An autoimmune disease of multifactorial etiology. Curr Opin Immunol 4: 760–765. [DOI] [PubMed] [Google Scholar]

[b1] 1. Rivers TM, Schwentker FF (1935) Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 61: 689–702. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b2] 2. Lumsden CE (1970) The neuropathology of multiple sclerosis In: Handbook of Clinical Neurology, Multiple Sclerosis and Other Demyelinating Diseases, Vol. 9, Vinken PJ, Bruyn GW. (eds.), pp. 217–309, North‐Holland: Amsterdam . [Google Scholar]

[b3] 3. Wisniewski HM, Schuller‐Levis GB, Mehta PD, Madrid RE, Lassmann H. (1985) Pathogenetic aspects of multiple sclerosis and experimental models of inflammatory demyelination. Concepts Immunopathol 2: 128–150. [PubMed] [Google Scholar]

[b4] 4. Allen IV (1991) Aetiological hypotheses for multiple sclerosis‐evidence from human and experimental diseases In: McAlpine's Multiple Sclerosis, Matthews WB, (ed.), pp. 379–390, Churchill Livingstone: Edinburgh , London , New York . [Google Scholar]

[b5] 5. Lassmann H., Wisniewski HM (1979) Chronic relapsing experimental allergic encephalomyelitis: Clinicopathological comparison with multiple sclerosis. Arch Neurol 36: 490–497. [DOI] [PubMed] [Google Scholar]

[b6] 6. Raine CS (1983) Multiple sclerosis and chronic relapsing EAE: Comparative ultrastructural neuropathology In: Multiple Sclerosis ‐ Pathology, Diagnosis and Management, Hallpike JF, Adams CWM, Tourtellotte WW. (eds.), pp. 413–460, Williams & Wilkins: Baltimore . [Google Scholar]

[b7] 7. Lisak RP (1986) Immunological abnormalities In: Multiple Sclerosis, McDonald WI, Silberberg DH. (eds.), pp. 74–98, Butterworths: London , Boston , Durban . [Google Scholar]

[b8] 8. Waksman BH (1988) Autoimmunity in demyelinating diseases. Ann N Y Acad Sci 540: 13–24. [DOI] [PubMed] [Google Scholar]

[b9] 9. Tournier‐Lasserve E., Hashim GA, Bach MA (1988) Human T cell response to myelin basic protein in multiple sclerosis patients and healthy subjects. J Neurosci Res 19: 149–156. [DOI] [PubMed] [Google Scholar]

[b10] 10. Traugott U. (1990) Evidence for immunopathogenesis In: Handbook of Multiple Sclerosis, Cook SD, (ed.), pp. 101–127, Marcell Dekker: New York . [Google Scholar]

[b11] 11. Raine CS (1991) Multiple sclerosis: A pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol 17: 265–274. [DOI] [PubMed] [Google Scholar]

[b12] 12. Lee SJ, Wucherpfennig KW, Brod SA, Benjamin D., Weiner HL, Hafler DA (1991) Common T cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol 29: 33–40. [DOI] [PubMed] [Google Scholar]

[b13] 13. Martin R., Howell MD, Jaraquemada D., Flerlage M., Richert JR, Brostoff S., Long EO, McFarlin DE, McFarland HF (1991) A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA‐DR types associated with multiple sclerosis. J Exp Med 173: 19–24. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b14] 14. Chou YK, Henderikx P., Vainiene M., Whitham R., Bourdette D., Chou CH, Hashim G., Offner H., Vandenbark AA (1991) Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein. J Neurosci Res 28: 280–290. [DOI] [PubMed] [Google Scholar]

[b15] 15. Oksenberg JR, Stuart S., Begovich AB, Bell RB, Erlich HA, Steinman L., Bernard CC (1990) Limited heterogeneity of rearranged T cell receptor V alpha transcripts in brains of multiple sclerosis patients. Nature 345: 344–346. [DOI] [PubMed] [Google Scholar]

[b16] 16. Ota K., Matsui M., Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183–187. [DOI] [PubMed] [Google Scholar]

[b17] 17. Vandenbark AA, Chou YK, Bourdette D., Whitham R., Chilgren J., Chou CH, Konat G., Hashim G., Vainiene M., Offner H. (1989) Human T lymphocyte response to myelin basic protein: Selection of T lymphocyte lines from MBP‐responsive donors. J Neurosci Res 23: 21–30. [DOI] [PubMed] [Google Scholar]

[b18] 18. Liblau R., Tournier‐Lasserve E., Maciazek J., Dumas G., Siffert O., Hashim G., Bach MA (1991) T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects. Eur J Immunol 21: 1391–1395. [DOI] [PubMed] [Google Scholar]

[b19] 19. Richert JR, Robinson ED, Martin R., McFarland HF, Hurley CK (1991) T cell receptor gene rearrangements in the human response to myelin basic protein. Ann N Y Acad Sci 636: 396–399. [DOI] [PubMed] [Google Scholar]

[b20] 20. Martin R., Utz U., Coligan JE, Richert JR, Flerlage M., Robinson ED, Stone R., Biddison WE, McFarlin DE, McFarland HF (1992) Diversity in fine specificity and T cell receptor usage of the human CD4⁺ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87–106. J Immunol 148: 1359–1366. [PubMed] [Google Scholar]

[b21] 21. Jingwu Z., Medaer R., Hashim GA, Chin Y., Van den Berg‐Loonen E. Raus JCM (1992) Myelin basic protein‐specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity. Ann Neurol 32: 330–338. [DOI] [PubMed] [Google Scholar]

[b22] 22. Leibowitz S. (1992) The immunology of multiple scleorsis In: Multiple Sclerosis‐Pathology, Diagnosis and Management, Hallpike JF, Adams CWM, Tourtellotte WW. (eds.), pp. 379–412, Williams & Wilkins: Baltimore . [Google Scholar]

[b23] 23. McFarland HF (1988) Immunology of multiple sclerosis. Ann N Y Acad Sci 540: 99–105. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b24] 24. Bradbury K. (1987) Serum demyelinating activity in multiple sclerosis In: Multiple Sclerosis: Immunological, Diagnostic, and Therapeutic Aspects, Rose FC, Jones R. (eds.), pp. 43–49, John Libby: London , Paris . [Google Scholar]

[b25] 25. Martin R., McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10: 153–187. [DOI] [PubMed] [Google Scholar]

[b26] 26. Neumeyer DA, Hirsch MS (1986) Inversion of T cell subsets before herpes zoster infection. New Engl J Med 314: 1456. [DOI] [PubMed] [Google Scholar]

[b27] 27. Saeki Y., Mima T., Sakoda S., Fujimura H., Arita N., Nomura T., Kishimoto T. (1992) Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc Natl Acad Sci USA 89: 6157–6161. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b28] 28. Lipton HL (1975) Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect Immun 11: 1147–1155. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b29] 29. Johnson RT (1985) Viral aspects of multiple sclerosis In: Handbook of Clinical Neurology, Demyelinating Diseases, Vol. 47, Koetsier JC, (ed.), pp. 319–336, Elsevier Science: Amsterdam , New York . [Google Scholar]

[b30] 30. Barnett LA, Fujinami RS (1992) Molecular mimicry: A mechanism for autoimmune injury. FASEB J 6: 840–844. [DOI] [PubMed] [Google Scholar]

[b31] 31. Booss J., Kim JH (1990) Evidence for a viral etiology of multiple sclerosis In: Handbook of Multiple Sclerosis, Cook SD, (ed.), pp. 41–61, Marcell Dekker: New York . [Google Scholar]

[b32] 32. Dal Canto MC, Rabinowitz SG (1982) Experimental models of virus‐induced demyelination of the central nervous system. Ann Neurol 11: 109–127. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b33] 33. Mims CA, Kelly RE, Cuzner ML (1983) Viruses and Demyelinating Diseases, Academic Press: London , New York . [Google Scholar]

[b34] 34. Rodriguez M., Oleszak E., Leibowitz J. (1987) Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus. CRC Crit Rev Immunol 7: 325–365. [PubMed] [Google Scholar]

[b35] 35. Watanabe R., Wege H., ter Meulen V. (1983) Adoptive transfer of EAE‐like lesions from rats with coronavirus‐induced demyelinating encephalomyelitis. Nature 305: 150–153. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b36] 36. Buchmeier MJ, Dalziel RG, Koolen MJM (1988) Corona‐virus‐induced CNS disease: A model for virus‐induced demyelination. J Neuroimmunol 20: 111–116. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b37] 37. Wege H., Winter J., Körner H., Flory E., Zimprich F., Lassmann H. (1990) Coronavirus induced demyelinating encephalomyelitis in rats: Immunopathological aspects of viral persistency. Adv Exp Med Biol 276: 637–645. [DOI] [PubMed] [Google Scholar]

[b38] 38. Johnson RT, Griffen DE, Hisrch RL, Wolinsky JS, Roedenbeck S., Lindo de Soriano I., Vaisberg A. (1984) Measles encephalomyelitis‐Clinical and immunological studies. N Engl J Med 310: 137–141. [DOI] [PubMed] [Google Scholar]

[b39] 39. Rodriguez M. (1992) Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. J Neuroimmunol 40: 255–264. [DOI] [PubMed] [Google Scholar]

[b40] 40. McFarlin DE, Blattner WA (1991) Non‐AIDS retroviral infections in humans. Annu Rev Med 42: 97–105. [DOI] [PubMed] [Google Scholar]

[b41] 41. Bray PF, Culp KW, McFarlin DE, Panitch HS, Torkelson RD, Schlight JP (1992) Demyelinating disease after neurologically complicated Epstein‐Barr virus infection. Neurology 42: 278–282. [DOI] [PubMed] [Google Scholar]

[b42] 42. Murray RS, Brown B., Brian D., Cabirac GF (1992) Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 31: 525–533. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b43] 43. Stewart JN, Mounir S., Talbot PJ (1992) Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 191: 502–505. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b44] 44. Kastrukoff LF, Lau AS, Leung GY, Walker D., Thomas EE (1992) Herpes simplex virus type 1‐induced multifocal central nervous system (CNS) demyelination in mice. J Neuropathol Exp Neurol 51: 432–439. [DOI] [PubMed] [Google Scholar]

[b45] 45. Cosby SL, Mcquaid S., Taylor MJ, Bailey M., Rima BK, Martin SJ, Allen IV (1989) Examination of eight cases of multiple sclerosis and 56 neurological and non‐neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol 70: 2027–2036. [DOI] [PubMed] [Google Scholar]

[b46] 46. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH (1971) Cultivation of papova‐like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1: 1257–1260. [DOI] [PubMed] [Google Scholar]

[b47] 47. Gardner SD, Field AM, Coleman DV, Hulme B. (1971) New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet i: 1253–1257. [DOI] [PubMed] [Google Scholar]

[b48] 48. Walker DL, Padgett BL (1983) The epidemiology of human polyomaviruses In: Polyomaviruses and Human Neurological Disease, Sever JL, Madden DL. (eds.), pp. 99–106, Alan R Liss: New York . [Google Scholar]

[b49] 49. Åström KE, Mancall EL, Richardson EP Jr, (1958) Progressive multifocal leuko‐encephalopathy: A hitherto unrecognized complication of chronic lymphocytic leukemia and Hodgkin's disease. Brain 81: 93–111. [DOI] [PubMed] [Google Scholar]

[b50] 50. Walker DL (1985) Progressive multifocal leukoencephalopathy In: Handbook of Clinical Neurology, Demyelinating Diseases, Vol. 47, Vinken PJ, Bruyn GW, Klawans HL, Koetsier JC. (eds.), pp. 503–524, Elsevier Science: Amsterdam , New York . [Google Scholar]

[b51] 51. Greenlee JE (1989) Papovavirus infections of the nervous system In: Clinical and Molecular Aspects of Neurotropic Virus Infection, Gilden DH, Lipton HL. (eds.), pp. 319–342, Kluwer Academic Publishers: Boston . [Google Scholar]

[b52] 52. Frisque RJ, White FA III (1992) The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy In: Neurovirology ‐ Pathogenesis of Viral CNS Infections, Roos RP, (ed.), pp. 25–158, Humana Press: Totowa . [Google Scholar]

[b53] 53. Major EO, Amemiya K., Tornatore CS, Houff SA, Berger JR (1992) Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus‐induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b54] 54. White FA III, Ishaq M., Stoner GL, Frisque RJ (1992) JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 66: 5726–5734. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b55] 55. Mori M., Aoki N., Shimada H., Tajima M., Kato K. (1992) Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci Lett 141: 151–155. [DOI] [PubMed] [Google Scholar]

[b56] 56. Quinlivan EB, Norris M., Bouldin TW, Suzuki K., Meeker R., Smith MS, Hall C., Kenney S. (1992) Subclinical central nervous system infection with JC virus in patients with AIDS. J Infect Dis 166: 80–85. [DOI] [PubMed] [Google Scholar]

[b57] 57. Elsner C., Dörries K. (1992) Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 191: 72–80. [DOI] [PubMed] [Google Scholar]

[b58] 58. Mori M., Kurata H., Tajima M., Shimada H. (1991) JC virus detection by in situ hybridization in brain tissue from elderly patients. Ann Neurol 29: 428–432. [DOI] [PubMed] [Google Scholar]

[b59] 59. Itoyama Y., Webster HdeF, Sternberger NH, Richardson EP Jr, Walker DL, Quarles RH, Padgett BL (1982) Distribution of papovavirus, myelin‐associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann Neurol 11: 396–407. [DOI] [PubMed] [Google Scholar]

[b60] 60. Johnson RT, Narayan O., Weiner LP, Greenlee JE (1977) Progressive multifocal leukoencephalopathy In: Slow Virus Infections of the Central Nervous System, TerMeulen V., Katz M. (eds.), pp. 91–105, Springer‐Verlag: New York . [Google Scholar]

[b61] 61. McDonald WI, Silberberg DH (1986) Multiple Sclerosis, Butterworths: London , Boston , Durban . [Google Scholar]

[b62] 62. Rose FC, Jones R. (1987) Multiple Sclerosis: Immunological, Diagnostic, and Therapeutic Aspects, John Libby: London , Paris . [Google Scholar]

[b63] 63. Cook SD (1990) Handbook of Multiple Sclerosis, Marcell Dekker: New York . [Google Scholar]

[b64] 64. Matthews WB, Compston A., Allen IV, Martyn CN (1991) McAlpine's Multiple Sclerosis, 2nd Ed, Churchill Livingstone: Edinburgh , London , New York . [Google Scholar]

[b65] 65. Howley PM (1980) Molecular biology of SV40 and the human polyomaviruses BK and JC In: Viral Oncology, Klein G., (ed.), pp. 489–550, Raven Press: New York . [Google Scholar]

[b66] 66. Padgett BL (1980) Human papovaviruses In: Molecular Biology of Tumor Viruses: DNA Tumor Viruses, Tooze J., (ed.), pp. 339–370, Cold Spring Harbor Laboratory: Cold Spring Harbor . [Google Scholar]

[b67] 67. ZuRhein GM (1983) Studies of JC virus‐induced nervous system tumors in the Syrian hamster In: Polyomaviruses in Human Neurological Diseases, Sever JL, Madden DL. (eds.), pp. 205–221, Alan R Liss: New York . [Google Scholar]

[b68] 68. Monier R. (1986) Transformation by SV40 and polyoma In: The Papovaviridae Volume 1 The Polyomaviruses, Salzman NP, (ed.), pp. 247–294, Plenum Press: New York , London . [Google Scholar]

[b69] 69. Villarreal LP (1989) Common Mechanisms of Transformation by Small DNA Tumor Viruses, American Society for Microbiology: Washington , D.C . [Google Scholar]

[b70] 70. London WT, Houff SA, Madden DL, Fuccillo DA, Gravell M., Wallen WC, Palmer AE, Sever JL, Padgett BL, Walker DL, ZuRhein GM, Ohashi T. (1978) Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201: 1246–1249. [DOI] [PubMed] [Google Scholar]

[b71] 71. Pagnani M., Negrini M., Reschiglian R. Corallini A., Balboni PG, Schemeck S., Macino G., Milanesi G., Barbanti‐Brodano G. (1986) Molecular and biological properties of BK virus‐IR, a BK virus variant isolated from a human tumor. J Virol 59: 500–505. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b72] 72. Dörries K., Loeber G., Meixensberger J. (1987) Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology 160: 268–270. [DOI] [PubMed] [Google Scholar]

[b73] 73. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 326: 988–993. [DOI] [PubMed] [Google Scholar]

[b74] 74. Gribble DH, Haden CC, Schwartz LW, Henrickson RV (1975) Spontaneous progressive multifocal leukoencephalopathy (PML) in macaques. Nature 254: 602–604. [DOI] [PubMed] [Google Scholar]

[b75] 75. Holmberg CA, Hendrickson R., Anderson J., Osburn BI (1985) Malignant lymphoma in a colony of Macaca arctoides. Vet Path 22: 42–45. [DOI] [PubMed] [Google Scholar]

[b76] 76. Horvath CJ, Simon MA, Bergsagel DJ, Pauley DR, King NW, Garcea RL, Ringler DJ (1992) Simian virus 40‐induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. Am J Pathol 140: 1431–1440. [PMC free article] [PubMed] [Google Scholar]

[b77] 77. Holmberg CA, Gribble DH, Takemoto KK, Howley PM, Espana C., Osburn BI (1977) Isolation of simian virus 40 from rhesus monkeys (Macaca mulatta) with spontaneous progressive multifocal leukoencephalopathy. J Infect Dis 136: 593–596. [DOI] [PubMed] [Google Scholar]

[b78] 78. Ilyinskii PO, Daniel MD, Horvath CJ, Desrosiers RC (1992) Genetic analysis of simian virus 40 from brains and kidneys of macaque monkeys. J Virol 66: 6353–6360. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b79] 79. Walker DL, Frisque RJ (1986) The biology and molecular biology of JC virus In: The Papovaviridae Volume 1 The Polyomaviruses, Salzman NP, (ed.), pp. 327–377, Plenum Press: New York . [Google Scholar]

[b80] 80. Stoner GL, Soffer D., Ryschkewitsch CF, Walker DL, Webster Hde F. (1988) A double‐label method detects both early (T‐antigen) and late (capsid) proteins of JC virus in progressive multifocal leukoencephalopathy brain tissue from AIDS and non‐AIDS patients. J Neuroimmunol 19: 223–236. [DOI] [PubMed] [Google Scholar]

[b81] 81. Richardson EP Jr (1961) Progressive multifocal leukoencephalopathy. New Engl J Med 265: 815–823. [DOI] [PubMed] [Google Scholar]

[b82] 82. Loeber G., Dörries K. (1988) DNA rearrangements in organ‐specific variants of polyomavirus JC strain GS. J Virol 62: 1730–1735. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b83] 83. Yogo Y., Kitamura T., Sugimoto C., Ueki T., Aso Y., Hara K., Taguchi F. (1990) Isolation of a possible archetypal JC virus DNA sequence from non‐immunocompromised individuals. J Virol 64: 3139–3143. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b84] 84. Buckle GJ, Godec MS, Rubi JU, Tornatore C., Major EO, Gajdusek DC, Asher DM (1992) Lack of JC viral genomic sequence in multiple sclerosis brain tissue by polymerase chain reaction. Ann Neurol 32: 829–831. [DOI] [PubMed] [Google Scholar]

[b85] 85. Heinonen O., Syrjänen S., Mäntyjärvi R., Syrjänen K., Riekkinen P. (1992) JC virus infection and Alzheimer's disease: Reappraisal of an in situ hybridization approach. Ann Neurol 31: 439–441. [DOI] [PubMed] [Google Scholar]

[b86] 86. Lipton HL (1991) Is JC virus latent in brain Ann Neurol 29: 433–434. [DOI] [PubMed] [Google Scholar]

[b87] 87. Budka H., Costanzi G., Cristina S., Lechi A., Parravicini C., Trabattoni R., Vago L. (1987) Brain pathology induced by infection with human immunodeficiency virus (HIV). A histological immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol (Berl) 75: 185–198. [DOI] [PubMed] [Google Scholar]

[b88] 88. Lang W., Miklossy J., Deruaz JP, Pizzolato GP, Probst A., Schaffner T., Gessaga E., Kleihues P. (1989) Neuropathology of the acquired immune deficiency syndrome (AIDS): A report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (Berl) 77: 379–390. [DOI] [PubMed] [Google Scholar]

[b89] 89. Chowdhury M., Taylor JP, Tada H., Rappaport J., Wong Staal F., Amini S., Khalili K. (1990) Regulation of the human neurotropic virus promoter by JCV‐T antigen and HIV‐1 tat protein. Oncogene 5: 1737–1742. [PubMed] [Google Scholar]

[b90] 90. Tada H., Rappaport J., Lashgari M., Amini S., Wong‐Staal F., Khalili K. (1990) Trans‐activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87: 3479–3483. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b91] 91. Chowdhury M., Taylor JP, Chang C‐F, Rappaport J., Khalili K. (1992) Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J Virol 66: 7355–7361. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b92] 92. Orenstein JM, Jannotta F. (1990) Human immunodeficiency virus and papovavirus infections in acquired immunodeficiency syndrome: An ultrastructural study of three cases. Hum Pathol 19: 350–361. [DOI] [PubMed] [Google Scholar]

[b93] 93. Wiley CA, Grafe M., Kennedy C., Nelson JA (1988) Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl) 76: 338–346. [DOI] [PubMed] [Google Scholar]

[b94] 94. Vazeux R., Cumont M., Girard PM, Nassif X., Trotot P., Marche C., Matthiessen L., Vedrenne C., Mikol J., Henin D. (1990) Severe encephalitis resulting from coinfections with HIV and JC virus. Neurology 40: 944–948. [DOI] [PubMed] [Google Scholar]

[b95] 95. Helland DE, Welles JL, Caputo A., Haseltine WA (1991) Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol 65: 4547–4549. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b96] 96. Marcuzzi A., Weinberger J., Weinberger OK (1992) Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J Virol 66: 4228–4232. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b97] 97. Rodriguez M., Pease LR, David CS (1986) Immune‐mediated injury of virus‐infected oligodendrocytes: A model of multiple sclerosis. Immunol Today 7: 359–363. [DOI] [PubMed] [Google Scholar]

[b98] 98. Stoner GL (1991) Implications of progressive multifocal leukoencephalopathy and JC virus for the etiology of MS. Acta Neurol Scand 83: 20–33. [PubMed] [Google Scholar]

[b99] 99. Phadke JG, Best PV (1983) Atypical and clinically silent multiple sclerosis: A report of 12 cases discovered unexpectedly at autopsy. J Neurol Neurosurg Psychiatry 46: 414–420. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b100] 100. Gilbert JJ, Sadler RM (1983) Unsuspected multiple sclerosis. Arch Neurol 40: 533–536. [DOI] [PubMed] [Google Scholar]

[b101] 101. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S., Hader W., Murray TJ, Seland TP, Duquette P., Grey T., Nelson R., Nicolle M., Brunet D. (1986) A population‐based study of multiple sclerosis in twins. N Engl J Med 315: 1638–1642. [DOI] [PubMed] [Google Scholar]

[b102] 102. Tienari PJ, Salonen O., Wikström J., Valanne L., Palo J. (1992) Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 55: 883–886. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b103] 103. Paty DW (1990) Neuroimaging in multiple sclerosis In: Handbook of Multiple Sclerosis, Cook SD, (ed), pp. 291–316, Marcell Dekker: New York . [Google Scholar]

[b104] 104. Coleman DV, Gardner SD, Mulholland C., Fridiksdottir V., Porter AA, Lilford R., Valdimarsson H. (1983) Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation. Clin Exp Immunol 53: 289–296. [PMC free article] [PubMed] [Google Scholar]

[b105] 105. Arthur RR, Shah KV (1989) Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol 36: 42–61. [PubMed] [Google Scholar]

[b106] 106. Markowitz R‐B, Thompson HC, Mueller JF, Cohen JA, Dynan WS (1993) Incidence of BK virus and JC virus viruria in human immunodeficiency virus‐infected and uninfected subjects. J Infect Dis 167: 13–20. [DOI] [PubMed] [Google Scholar]

[b107] 107. Brinton MA, Blank KJ, Nathanson N. (1984) Host genes that influence susceptibility to viral diseases In: Concepts in Viral Pathogenesis, Notkins AL, Oldstone MBA. (eds.), pp. 71–78, Springer‐Verlag: New York . [Google Scholar]

[b108] 108. Skamene E., Pietrangeli CE (1991) Genetics of the immune response to infectious pathogens. Curr Opin Immunol 3: 511–517. [DOI] [PubMed] [Google Scholar]

[b109] 109. Oksenberg JR, Steinman L. (1989) The role of the MHC and T cell receptor in susceptibility to multiple sclerosis. Curr Opin Immunol 2: 619–621. [DOI] [PubMed] [Google Scholar]

[b110] 110. Yogo Y., Iida T., Taguchi F., Kitamura T., Aso Y. (1991) Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J Clin Microbiol 29: 2130–2138. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b111] 111. Ault GS, Stoner GL (1992) Two major types of JC virus defined in PML brain by early and late region DNA coding sequence. J Gen Virol 73: 2669–2678. [DOI] [PubMed] [Google Scholar]

[b112] 112. Fanning E., Knippers R. (1992) Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem 61: 55–85. [DOI] [PubMed] [Google Scholar]

[b113] 113. Kuroiwa Y., Kurland LT (1982) Multiple Sclerosis East and West, Karger: Basel . [Google Scholar]

[b114] 114. Begovich AB, Helmuth RC, Oksenberg JR, Sakai K., Tabira T., Sasazuki T., Steinman L., Erlich HA (1990) HLA‐DP beta and susceptibility to multiple sclerosis: An analysis of caucasoid and Japanese patient populations. Hum Immunol 28: 365–372. [DOI] [PubMed] [Google Scholar]

[b115] 115. Chittenden T., Frey A., Levine AJ (1991) Regulated replication of an episomal simian virus 40 origin plasmid in COS7 cells. J Virol 65: 5944–5951. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b116] 116. Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51: 458–469. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b117] 117. Dörries K., ter Meulen V. (1983) Progressive multifocal leucoencephalopathy: Detection of papovavirus JC in kidney tissue. J Med Virol 11: 307–317. [DOI] [PubMed] [Google Scholar]

[b118] 118. Grinnell BW, Padgett BL, Walker DL (1983) Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy. J Infect Dis 147: 669–675. [DOI] [PubMed] [Google Scholar]

[b119] 119. Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S., Roberts JR, Gitt J., Saini N., Lux W. (1988) Involvement of JC virus‐infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318: 301–305. [DOI] [PubMed] [Google Scholar]

[b120] 120. Stoner GL, Mazlo M., Ryschkewitsch CF, Walker DL, Webster Hde F. (1988) Cerebellar progressive multifocal leukoencephalopathy: Localization of JC virus T‐antigen in granule cell neurons. Ann Neurol 24: 475 (abstr). [Google Scholar]

[b121] 121. Stoner GL, Ryschkewitsch CF, Walker DL, Webster Hde F. (1986) JC papovavirus large tumor (T)‐antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non‐AIDS patients with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 83: 2271–2275. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b122] 122. Dörries K., Johnson RT, ter Meulen V. (1979) Detection of polyoma virus DNA in PML‐brain tissue by (in situ) hybridization. J Gen Virol 42: 49–57. [DOI] [PubMed] [Google Scholar]

[b123] 123. Fareed GC, Takemoto KK, Gimbrone MA Jr (1978) Interaction of simian virus 40 and human papovaviruses, BK and JC, with human vascular endothelial cells In: Microbiology ‐ 1978, Schlessinger D., (ed.), pp. 427–431, American Society for Microbiology: Washington , D.C . [Google Scholar]

[b124] 124. Ressetar HG, Webster Hde F., Stoner GL (1992) Brain vascular endothelial cells express JC virus large tumor antigen in immunocompetent and cyclophosphamide‐treated hamsters. Proc Natl Acad Sci USA 89: 8170–8174. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b125] 125. Pardridge WM (1992) Advances in cell biology of blood‐brain barrier transport. Sem Cell Biol 2: 419–426. [PubMed] [Google Scholar]

[b126] 126. Babé LM, Brew K., Matsuura SE, Scott WA (1989) Epitopes on the major capsid protein of simian virus 40. J Biol Chem 264: 2665–2671. [PubMed] [Google Scholar]

[b127] 127. Ressetar HG, Walker DL, Webster Hde F., Braun DG, Stoner GL (1990) Immunolabeling of JC virus large T antigen in neonatal hamster brain before tumor formation. Lab Invest 62: 287–296. [PubMed] [Google Scholar]

[b128] 128. Adams JH, Short IA (1965) Progressive multifocal leucoencephalopathy. A neurological complication of diseases involving the reticulo‐endothelial system. Scot Med J 10: 195–202. [PubMed] [Google Scholar]

[b129] 129. D'Agostino AN, Pease GL, Kernohan JW (1963) Cerebral demyelination associated with polycythemia vera. J Neuropathol Exp Neurol 22: 138–147. [DOI] [PubMed] [Google Scholar]

[b130] 130. Zu Rhein GM (1969) Association of papova‐virions with a human demyelinating disease (progressive multifocal leukoencephalopathy). Prog Med Virol 11: 185–247. [PubMed] [Google Scholar]

[b131] 131. Chandor SB, Forno LS, Wivel NA (1965) Progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 28: 260–271. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b132] 132. Åström KE, Stoner GL (1990) Asymptomatic progressive multifocal leukoencephalopathy (PML) with early lesions discovered at autopsy. J Neuropathol Exp Neurol 49: 302 (abstr). [Google Scholar]

[b133] 133. Sloof JL (1966) Two cases of progressive multifocal leukoencephalopathy with unusual aspects. Psychiat Neurol Neurochir 69: 461–474. [PubMed] [Google Scholar]

[b134] 134. Watanabe I., Preskorn SH (1976) Virus‐cell interaction in oligodendroglia, astroglia and phagocyte in progressive multifocal leukoencephalopathy. An electron microscopic study. Acta Neuropathol (Berl) 36: 101–115. [DOI] [PubMed] [Google Scholar]

[b135] 135. Mázlô M., Tariska I (1982) Are astrocytes infected in progressive multifocal leukoencephalopathy (PML) Acta Neuropathol (Berl) 56: 45–51. [DOI] [PubMed] [Google Scholar]

[b136] 136. Johnson RT, Mims CA (1968) Pathogenesis of viral infections of the nervous system. New Engl J Med 278: 84–92. [DOI] [PubMed] [Google Scholar]

[b137] 137. Knowles WA, Gibson PE, Gardner SD (1989) Serological typing scheme for BK‐like isolates of human polyomavirus. J Med Virol 28: 118–123. [DOI] [PubMed] [Google Scholar]

[b138] 138. Tavis JE, Frisque RJ, Walker DL, White FA III (1990) Antigenic and transforming properties of the DB strain of the human polyomavirus BK virus. Virology 178: 568–572. [DOI] [PubMed] [Google Scholar]

[b139] 139. Tavis JE, Walker DL, Gardner SD, Frisque RJ (1989) Nucleotide sequence of the human polyomavirus AS virus, an antigenic variant of BK virus. J Virol 63: 901–911. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b140] 140. Negrini M., Sabbioni S., Arthur RR, Castagnoli A., Barbanti Brodano G. (1991) Prevalence of the archetypal regulatory region and sequence polymorphisms in non‐passaged BK virus variants. J Virol 65: 5092–5095. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b141] 141. Willoughby E., Price RW, Padgett BL, Walker DL, Dupont B. (1980) Progressive multifocal leukoencephalopathy (PML): In vitro cell‐mediated immune responses to mitogens and JC virus. Neurology 30: 256–262. [DOI] [PubMed] [Google Scholar]

[b142] 142. Drummond JE, Shah KV, Donnenberg AD (1985) Cell‐mediated immune responses to BK virus in normal individuals. J Med Virol 17: 237–247. [DOI] [PubMed] [Google Scholar]

[b143] 143. Dupuis M., Fernandes Xavier FG, Gonsette RE, Brucher JM (1986) Progressive multifocal leukoencephalopathy mimicking multiple sclerosis as only manifestation of an acquired immune deficiency syndrome. Acta Neurol Belg 86: 285–296. [PubMed] [Google Scholar]

[b144] 144. Berger JR, Sheremata WA, Resnick L., Atherton S., Fletcher MA, Norenberg M. (1989) Multiple sclerosis like illness occurring with human immunodeficiency virus infection. Neurology 39: 324–329. [DOI] [PubMed] [Google Scholar]

[b145] 145. Brew BJ (1991) MS‐like leukoencephalopathy in HIV‐1. Neurology 41: 1166. [DOI] [PubMed] [Google Scholar]

[b146] 146. Gray F., Chimelli L., Mohr M., Clavelou P., Scaravilli F., Poirier J. (1991) Fulminating multiple sclerosis‐like leukoencephalopathy revealing human immunodeficiency virus infection. Neurology 41: 105–109. [DOI] [PubMed] [Google Scholar]

[b147] 147. Berger JR, Tornatore C., Major EO, Bruce J., Shapshak P., Yoshioka M., Houff S., Sheremata W., Horton GF, Landy H. (1992) Relapsing and remitting human immunodeficiency virus‐associated leukoencephalomyelopathy. Ann Neurol 31: 34–38. [DOI] [PubMed] [Google Scholar]

[b148] 148. Upton H., Miller S., Melvold R., Fujinami RS (1986) Theiler's murine encephalomyelitis virus (TMEV) infection in mice as a model for multiple sclerosis In: Concepts in Viral Pathogenesis II, Notkins AL, Oldstone MBA. (eds.), pp. 248–254, Springer‐Verlag: New York . [Google Scholar]

[b149] 149. Small JA, Scangos GA, Cork L., Jay G., Khoury G. (1986) The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell 46: 13–18. [DOI] [PubMed] [Google Scholar]

[b150] 150. Trapp BD, Small JA, Pulley M., Khoury G., Scangos GA (1988) Dysmyelination in transgenic mice containing JC virus early region. Ann Neurol 23: 38–48. [DOI] [PubMed] [Google Scholar]

[b151] 151. Baron‐Van Evercooren A., Jensen NA, Wyss MT, Cuzin F., Rassoulzadegan M., Brucher JM, Baron H. (1992) Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system. Lab Invest 66: 39–53. [PubMed] [Google Scholar]

[b152] 152. Hogan TF, Padgett BL, Walker DL (1991) Human Polyomaviruses In: Textbook of Human Virology, Belshe RB, (ed.), pp. 970–1000, Mosby: St. Louis . [Google Scholar]

[b153] 153. Meurman OH, Mäntyjärvi RA, Salmi AA, Panelius M. (1972) Prevalence of antibodies to a human papova virus (BK virus) in subacute sclerosing panencephalitis and multiple sclerosis patients. Z Neurol 203: 191–194. [DOI] [PubMed] [Google Scholar]

[b154] 154. Roizin L., Haymaker W., D'Amelio F. (1982) Disease states involving the white matter of the central nervous system. Part I. The primary demyelinating diseases In: Histology and Histopathology of the Nervous System, Haymaker W., Adams RD. (eds.), pp. 1276–1361, Charles C Thomas: Springfield . [Google Scholar]

[b155] 155. Fog T. (1965) The topography of plaques in multiple sclerosis. Acta Neurol Scand (Suppl) 15: 1–161. [PubMed] [Google Scholar]

[b156] 156. Harris JO, Frank JA, Patronas N., McFarlin DE, McFarland HF (1991) Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history. Ann Neurol 29: 548–555. [DOI] [PubMed] [Google Scholar]

[b157] 157. Thompson AJ, Kermode AG, Wicks D., MacManus DG, Kendall BE, Kingsley DP, McDonald WI (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29: 53–62. [DOI] [PubMed] [Google Scholar]

[b158] 158. McDonald WI, Barnes D. (1989) Lessons from magnetic resonance imaging in multiple sclerosis. Trends Neurosci 12: 376–379. [DOI] [PubMed] [Google Scholar]

[b159] 159. ZuRhein GM, Varakis JN (1979) Perinatal induction of medulloblastomas in Syrian golden hamsters by a human polyoma virus (JC) In: Perinatal Carcinogenesis, National Cancer Institute Monograph 51, Rice JM, (ed.), pp. 205–208, U.S. Dept. of Health, Education and Welfare: Washington , D.C . [PubMed] [Google Scholar]

[b160] 160. Takakura K., Inoya H., Nagashima K. (1987) Viral neurooncogenesis. Prog Exp Tumor Res 30: 10–20. [PubMed] [Google Scholar]

[b161] 161. Reagan TJ, Freiman IS (1973) Multiple cerebral gliomas in multiple sclerosis. J Neurol Neurosurg Psychiatry 36: 523–528. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b162] 162. Russell DS, Rubinstein LJ (1977) Pathology of Tumors of the Nervous System, 4th Ed, p. 271, Williams & Wilkins: Baltimore . [Google Scholar]

[b163] 163. Anderson M., Hughes B., Jefferson M., Smith WT, Waterhouse JAH (1980) Gliomatous transformation and demyelinating diseases. Brain 103: 603–622. [DOI] [PubMed] [Google Scholar]

[b164] 164. Malmgren RM, Detels R., Verity MA (1984) Co‐occurrence of multiple sclerosis and glioma ‐ Case report and neuropathology and epidemiologic review. Clin Neuropath 3: 1–9. [PubMed] [Google Scholar]

[b165] 165. Turpin JC, Peruzzi P., Pluot M. (1988) Sclérose en plaques et gliome cérébral. Sem Hôp Paris 64: 1151–1158. [Google Scholar]

[b166] 166. Aarli JA, Mörk SJ, Myrseth E., Larsen JL (1989) Glioblastoma associated with multiple sclerosis: Coincidence or induction Eur Neurol 29: 312–316. [DOI] [PubMed] [Google Scholar]

[b167] 167. Castaigne P., Rondot P., Escourolle R., Ribadeau dumas JL, Cathala F., Hauw JJ (1974) Leucoencephalopathie multifocale progressive et ‘gliomes’ multiples. Rev Neurol (Paris) 130: 379–392. [PubMed] [Google Scholar]

[b168] 168. Sima AA, Finkelstein SD, McLachlan DR (1983) Multiple malignant astrocytomas in a patient with spontaneous progressive multifocal leukoencephalopathy. Ann Neurol 14: 183–188. [DOI] [PubMed] [Google Scholar]

[b169] 169. Shepherd DI, Downie AW, Best PV (1974) Systemic lupus erythematosis and multiple sclerosis. Trans Am Neurol Assoc 99: 173–176. [PubMed] [Google Scholar]

[b170] 170. Newton P., Aldridge RD, Lessells AM, Best PV (1986) Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus. Arthritis Rheum 29: 337–343. [DOI] [PubMed] [Google Scholar]

[b171] 171. Stoner GL, Best PV, Mazlo M., Ryschkewitsch CF, Walker DL, Webster Hde F. (1988) Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus: Distribution of JC virus in chronically demyelinated cerebellar lesions. J Neuropathol Exp Neurol 47: 307 (abstr). [Google Scholar]

[b172] 172. Poser CM (1992) Multiple sclerosis. Observations and reflections‐A personal memoir. J Neurol Sci 107: 127–140. [DOI] [PubMed] [Google Scholar]

[b173] 173. Selmaj K., Raine CS, Cannella B., Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949–954. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b174] 174. Hughes RAC (1992) Pathogenesis of multiple sclerosis. J R Soc Med 85: 373–376. [PMC free article] [PubMed] [Google Scholar]

[b175] 175. Selmaj K., Raine CS, Cross AH (1991) Anti‐tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30: 694–700. [DOI] [PubMed] [Google Scholar]

[b176] 176. Steinman L. (1991) The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv Immunol 49: 357–379. [DOI] [PubMed] [Google Scholar]

[b177] 177. Hafler DA, Cohen I., Benjamin DS, Weiner HL (1992) T cell vaccination in multiple sclerosis: A preliminary report. Clin Immunol Immunopathol 62: 307–313. [DOI] [PubMed] [Google Scholar]

[b178] 178. Arnason BGW (1992) Multiple sclerosis: Additional thoughts. J Neurol Sci 107: 141–144. [DOI] [PubMed] [Google Scholar]

[b179] 179. Hillert J., Olerup O. (1992) Debate: Do TCR genes influence susceptibility to autoimmune disease in humans? Germline polymorphism of TCR genes and disease susceptibility ‐ Fact or hypothesis. Immunol Today 13: 47–49. [DOI] [PubMed] [Google Scholar]

[b180] 180. Webb HE (1992) Multiple sclerosis: Therapeutic pessimism. Brit Med J 304: 1260–1261. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b181] 181. Weinshenker BG, Sibley WA (1992) Natural history and treatment of multiple sclerosis. Curr Opin Neurol Neurosurg 5: 203–211. [PubMed] [Google Scholar]

[b182] 182. Bernard CCA, de Rosbo NK (1992) Multiple sclerosis: An autoimmune disease of multifactorial etiology. Curr Opin Immunol 4: 760–765. [DOI] [PubMed] [Google Scholar]

PERMALINK

Polyomavirus Models of Brain Infection and the Pathogenesis of Multiple Sclerosis

Gerald L Stoner

Abstract

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Polyomavirus Models of Brain Infection and the Pathogenesis of Multiple Sclerosis

Gerald L Stoner

Abstract

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases